Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2011-06-28
2011-06-28
Liu, Sue (Department: 1639)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S402000
Reexamination Certificate
active
07968681
ABSTRACT:
Polypeptides comprising monomer domains that bind to c-MET, or portions thereof, are provided.
REFERENCES:
patent: 6703491 (2004-03-01), Homburger et al.
patent: 2003/0078737 (2003-04-01), Keys et al.
patent: 2003/0082575 (2003-05-01), Schultz et al.
patent: 2003/0082630 (2003-05-01), Kolkman et al.
patent: 2004/0175756 (2004-09-01), Kolkman et al.
patent: 2005/0048512 (2005-03-01), Kolkman et al.
patent: 2005/0053973 (2005-03-01), Kolkman et al.
patent: 2005/0089932 (2005-04-01), Kolkman et al.
patent: 2005/0164301 (2005-07-01), Kolkman et al.
patent: 2005/0214859 (2005-09-01), Dransfield et al.
patent: WO 02/16600 (2002-02-01), None
patent: WO 02/068649 (2002-09-01), None
patent: WO 02/088171 (2002-11-01), None
Office Action (Restriction Requirement) mailed Aug. 21, 2007, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Amendment and Response to Restriction Requirement filed Nov. 21, 2007, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Office Action (Restriction Requirement) mailed Feb. 26, 2008, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Amendment and Response to Restriction Requirement filed Mar. 27, 2008, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Office Action mailed Jul. 7, 2008, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Amendment and Response to Office Action filed Oct. 7, 2008, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Office Action mailed Feb. 4, 2009, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Amendment and Response to Office Action filed May 4, 2009, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Applicant Interview Summary filed Aug. 7, 2009, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Notice of Allowance and Fee(s) Due, Notice of Allowability with Examiner Interview Summary, and Examiner's Amendment mailed Aug. 13, 2009, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Notice of Allowance and Fee(s) Due mailed Jan. 11, 2010, for U.S. Appl. No. 11/155,989, filed Jun. 17, 2005.
Communication enclosing a Supplemental European Search Report for EP Application No. 05787547.8, mailed Jul. 28, 2009 (6 pages).
Database Geneseq [Online], “Human A domain from LRP2 #21,” retrieved from EBI Accession No. GSP: ABU61331, May 8, 2003 (2 pages).
Database EPO Proteins [Online], “Sequence 85 from Patent WO0216600,” retrieved from EBI Accession No. EPOP: AX449750, Jul. 2, 2002 (1 page).
Database EPO Proteins [Online], “Sequence 814 from Patent WO02068649,” retrieved from EBI Accession No. EPOP: AX922474, Dec. 18, 2003 (1 page).
Nielsen et al., Segments in the C-terminal Folding Domain of Lipoprotein Lipase Important for Binding to the Low Density Lipoprotein Receptor-related Protein and to Heparan Sulfate Proteoglycans,J. Biol. Chem., 272(9): 5821-5827 (1997).
Desantis et al., “Chemical modification of enzymes for enhanced functionality,”Current Opin. Biotech., 10: 324-330 (1999).
Esser et al., “Mutational Analysis of the Ligand Binding Domain of the Low Density Lipoprotein Receptor,”J. Biol. Chem., 263(26): 13282-13290 (1988).
Russell et al., “Different Combinations of Cysteine-Rich Repeats Mediate Binding of Low Density Lipoprotein Receptor to Two Different Proteins,” J. Biol. Chem., 264(36): 21682-21688 (1989).
Communication enclosing an extended European Search Report and Search Opinion for EP Application No. 09176476.1, mailed Jan. 7, 2010 (7 pages).
Maulik et al., “Role of the Hepatocyte Growth Factor Receptor, c-Met, in Oncogenesis and Potential for Therapeutic Inhibition,” Cytokine Growth Factor Reviews 13(1): 41-59 (2002).
Peschard et al., “Mutation of the c-Cbl TKB Domain Binding Site on the Met Receptor Tyrosine Kinase Converts It into a Transforming Protein,” Mol. Cell 8(5): 995-1004 (2001).
Alba Benjamin M.
Bakker Alice
Duguay Amy N.
Lui Qiang
Perlroth D. Victor
Amgen Mountain View Inc.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Liu Sue
LandOfFree
c-MET kinase binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with c-MET kinase binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and c-MET kinase binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2717385